• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动神经元病的神经代谢改变:磁共振波谱的启示。

Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy.

机构信息

Medical Physics Laboratory, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian University of Athens, 11522 Athens, Greece.

出版信息

J Integr Neurosci. 2022 Apr 24;21(3):87. doi: 10.31083/j.jin2103087.

DOI:10.31083/j.jin2103087
PMID:35633168
Abstract

Magnetic resonance spectroscopy (MRS) has contributed important academic insights in motor neuron diseases (MNDs), particularly in amyotrophic lateral sclerosis (ALS). Over the past three decades momentous methodological advances took place, including the emergence of high-field magnetic resonance imaging (MRI) platforms, multi-voxel techniques, whole-brain protocols, novel head-coil designs, and a multitude of open-source imaging suites. Technological advances in MRS are complemented by important conceptual developments in MND, such as the recognition of the importance of extra-motor brain regions, multi-timepoint longitudinal study designs, assessment of asymptomatic mutation carriers, description of genotype-associated signatures, and the gradual characterisation of non-ALS MND phenotypes. We have conducted a systematic review of published MRS studies in MND to identify important emerging research trends, key lessons from pioneering studies, and stereotyped shortcomings. We also sought to highlight notable gaps in the current literature so that research priorities for future studies can be outlined. While MRS remains relatively underutilised in MND compared to other structural, diffusivity and functional imaging modalities, our review suggests that MRS can not only advance our academic understanding of MND biology, but has a multitude of practical benefits for clinical and pharmaceutical trial applications.

摘要

磁共振波谱(MRS)在运动神经元疾病(MNDs),特别是肌萎缩侧索硬化症(ALS)的研究中提供了重要的学术见解。在过去的三十年中,发生了重大的方法学进展,包括高磁场磁共振成像(MRI)平台、多体素技术、全脑方案、新型头线圈设计以及众多开源成像套件的出现。MRS 的技术进步与 MND 中的重要概念发展相辅相成,例如认识到运动外脑区的重要性、多时间点纵向研究设计、对无症状突变携带者的评估、描述与基因型相关的特征以及逐渐描述非 ALS MND 表型。我们对 MND 中的已发表 MRS 研究进行了系统综述,以确定重要的新兴研究趋势、开创性研究的关键经验教训和常见的缺点。我们还试图突出当前文献中的显著差距,以便为未来的研究确定研究重点。虽然与其他结构、弥散和功能成像模式相比,MRS 在 MND 中的应用相对较少,但我们的综述表明,MRS 不仅可以促进我们对 MND 生物学的学术理解,而且对临床和药物试验应用具有多种实际益处。

相似文献

1
Neurometabolic Alterations in Motor Neuron Disease: Insights from Magnetic Resonance Spectroscopy.运动神经元病的神经代谢改变:磁共振波谱的启示。
J Integr Neurosci. 2022 Apr 24;21(3):87. doi: 10.31083/j.jin2103087.
2
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.运动神经元病/肌萎缩侧索硬化症患者流涎(唾液过多)的治疗。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3.
3
Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病中疲劳的治疗
Cochrane Database Syst Rev. 2018 Jan 2;1(1):CD011005. doi: 10.1002/14651858.CD011005.pub2.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
Coping in people with amyotrophic lateral sclerosis and motor neuron disease: Systematic review.肌萎缩侧索硬化症和运动神经元病患者的应对方式:系统评价。
J Clin Nurs. 2021 Jul;30(13-14):1838-1853. doi: 10.1111/jocn.15692. Epub 2021 Feb 19.
6
The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.C9orf72 六核苷酸重复扩展的影像学特征:对临床试验和治疗开发的影响。
Brain Imaging Behav. 2021 Oct;15(5):2693-2719. doi: 10.1007/s11682-020-00429-w. Epub 2021 Jan 5.
7
Amino acids for amyotrophic lateral sclerosis / motor neuron disease.用于肌萎缩侧索硬化症/运动神经元病的氨基酸
Cochrane Database Syst Rev. 2003(4):CD003457. doi: 10.1002/14651858.CD003457.
8
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).利鲁唑用于治疗肌萎缩侧索硬化症(ALS)/运动神经元病(MND)。
Cochrane Database Syst Rev. 2002(2):CD001447. doi: 10.1002/14651858.CD001447.
9
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
10
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的肠内管饲喂养
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004030. doi: 10.1002/14651858.CD004030.pub2.

引用本文的文献

1
Magnetic Resonance Neuroimaging in Amyotrophic Lateral Sclerosis: A Comprehensive Umbrella Review of 18 Studies.肌萎缩侧索硬化症的磁共振神经成像:18项研究的综合概述性综述
Brain Sci. 2025 Jul 3;15(7):715. doi: 10.3390/brainsci15070715.
2
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications.肌萎缩侧索硬化症中的新兴生物标志物:从发病机制到临床应用
Front Mol Biosci. 2025 Jun 30;12:1608853. doi: 10.3389/fmolb.2025.1608853. eCollection 2025.
3
New developments in imaging in ALS.肌萎缩侧索硬化症成像技术的新进展。
J Neurol. 2025 May 12;272(6):392. doi: 10.1007/s00415-025-13143-8.
4
Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases.基因组学和转录组学方法推动神经退行性疾病的诊断与预后研究。
Genes (Basel). 2025 Jan 24;16(2):135. doi: 10.3390/genes16020135.
5
Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome.小儿遗传性运动神经元病的研究进展:临床特征与预后
Genes (Basel). 2024 Oct 21;15(10):1346. doi: 10.3390/genes15101346.
6
Metabolite profile in hereditary spastic paraplegia analyzed using magnetic resonance spectroscopy: a cross-sectional analysis in a longitudinal study.使用磁共振波谱分析遗传性痉挛性截瘫的代谢物谱:一项纵向研究中的横断面分析。
Front Neurosci. 2024 Aug 13;18:1416093. doi: 10.3389/fnins.2024.1416093. eCollection 2024.
7
Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in and -Negative Patients.边缘系统网络和帕佩兹环路与肌萎缩侧索硬化症的关系:C9orf72基因中GGGGCC六核苷酸重复序列携带者及阴性患者的影像学和临床特征
Biology (Basel). 2024 Jul 6;13(7):504. doi: 10.3390/biology13070504.
8
Biomarkers in amyotrophic lateral sclerosis: current status and future prospects.肌萎缩侧索硬化症中的生物标志物:现状与未来展望。
Nat Rev Neurol. 2023 Dec;19(12):754-768. doi: 10.1038/s41582-023-00891-2. Epub 2023 Nov 10.
9
Language deficits in primary lateral sclerosis: cortical atrophy, white matter degeneration and functional disconnection between cerebral regions.原发性侧索硬化症中的语言缺陷:皮质萎缩、白质变性及脑区之间的功能脱节。
J Neurol. 2024 Jan;271(1):431-445. doi: 10.1007/s00415-023-11994-7. Epub 2023 Sep 27.
10
Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.肌萎缩侧索硬化症家系的无症状期灰质改变:无症状 C9orf72 和 SOD1 突变携带者的计算神经影像学研究。
J Neurol. 2023 Sep;270(9):4235-4247. doi: 10.1007/s00415-023-11764-5. Epub 2023 May 13.